Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q2 FY26
Investor Presentation
Q2 FY25
Investor Presentation
Q1 FY25
Investor Presentation
Q4 FY24
Investor Presentation
Q3 FY19
Discovery themes featuring this stockDeccan Health Care Ltd (DECCAN) is currently trading at 13.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Deccan Health Care Limited specializes in developing, manufacturing, and marketing nutraceutical, cosmeceutical, and ayurveda products. The company has shown impressive year-on-year revenue growth, driven by product diversification and market expansion in digital and retail sectors. With a strong presence in functional foods, Deccan Health Care capitalizes on the growing demand for health-centric products by focusing on science-backed formulations and engaging consumer wellness programs. Deccan Health Care's recent aggressive international expansion, seen via regulatory filings in six new markets and targeted launches in UAE and GCC, highlights its strategic focus on global growth. The company demonstrates sound governance with zero investor complaints, timely compliance, and a commitment to science-driven innovation, reinforcing its brand reputation in the health sector.
Over the past 52 weeks, Deccan Health Care Ltd has traded between a low of ₹6.65 and a high of ₹21.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Deccan Health Care Ltd has a market capitalization of approximately 32.22. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Deccan Health Care Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.99 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 32.22 Cr, Deccan Health Care Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Deccan Health Care Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Deccan Health Care Ltd is 12.99. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
AGM/EGM Notice
Deccan Health Care Ltd files consolidated scrutinizer report and voting results for 1st Extra-Ordinary General Meeting held on 24 July 2026; appointments of three independent directors approved with ~99.96% votes in favour.
AGM/EGM Notice
Deccan Health Care Ltd filed the consolidated scrutinizer's report and voting results for the 1st EGM held on 2026-07-24; three independent director appointments were approved (~99.96% votes in favour).
Bearish
4
Neutral
6
Bullish
4
Bearish
6
Neutral
6
Bullish
34
Bearish
2
Neutral
0
Bullish
30
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
114.10 | 38 Cr | 22.10 | 1.14 | 3.07 | 5.17 | 6.31 | 4.88 | ||
20.51 | 37 Cr | 112.18 | 1.38 | 0.00 | 1.67 | 3.84 | 0.69 | ||
99.75 | 33 Cr | 26.18 | 2.55 | 0.00 | 9.06 | 9.88 | 3.80 | ||
13.10 | 32 Cr | 12.99 | 0.29 | 0.00 | 2.26 | 3.18 | 1.67 | ||
13.64 | 27 Cr | 22.52 | 1.01 | 0.00 | 4.52 | 6.35 | 3.93 | ||
36.50 | 27 Cr | -23.42 | 0.00 | 0.00 | 36.33 | -3.29 | -5.41 | ||
10.64 | 24 Cr | -3.01 | 2.06 | 0.00 | -69.43 | -64.75 | -60.50 | ||
| Median: 7 Co. | — | 20.51 | 32 Cr | 22.10 | 1.14 | 0.00 | 4.52 | 3.84 | 1.67 |
Deccan Health Care Limited specializes in developing, manufacturing, and marketing nutraceutical, cosmeceutical, and ayurveda products. The company has shown impressive year-on-year revenue growth, driven by product diversification and market expansion in digital and retail sectors.
With a strong presence in functional foods, Deccan Health Care capitalizes on the growing demand for health-centric products by focusing on science-backed formulations and engaging consumer wellness programs.
Deccan Health Care's recent aggressive international expansion, seen via regulatory filings in six new markets and targeted launches in UAE and GCC, highlights its strategic focus on global growth.
The company demonstrates sound governance with zero investor complaints, timely compliance, and a commitment to science-driven innovation, reinforcing its brand reputation in the health sector.
Healthcare Services
Healthcare Service Provider
32 Cr
Moderate Risk
13.0
64.9
0.2
0.3
21.20
6.65
Sales CAGR
Profit CAGR
ROE
ROCE
